Evidence for gene-nutrient interaction at the PPARgamma locus - PubMed (original) (raw)
Evidence for gene-nutrient interaction at the PPARgamma locus
J Luan et al. Diabetes. 2001 Mar.
Abstract
The importance of the nuclear receptor peroxisome proliferator-activated receptor-gamma (PPARgamma) in regulating insulin resistance and blood pressure has been demonstrated in families with loss of function mutations. Gain of function mutations has been associated with severe obesity. However, previous population studies of the common variant Pro12Ala have produced conflicting results. As it is likely that the natural ligands for this receptor may include fatty acids, we hypothesized that the effect of this common variant may be altered by the character of the diet, particularly the ratio of dietary polyunsaturated fat to saturated fat (P:S ratio). We studied 592 nondiabetic participants in an ongoing population-based cohort study who were genotyped for the Pro12Ala polymorphism in the PPAR gamma2 isoform. As the Ala homozygotes were uncommon (2.0%), all analyses were conducted comparing Pro homozygotes (79.1%) to Ala allele carriers. There was no difference in fasting insulin concentration or BMI between Ala allele carriers and Pro homozygotes. The fasting insulin concentration was negatively associated with the P:S ratio (P = 0.0119) after adjustment for age and sex, and a strong interaction was evident between the P:S ratio and the Pro12Ala polymorphism for both BMI (P = 0.0038) and fasting insulin (P = 0.0097). The data suggest that when the dietary P:S ratio is low, the BMI in Ala carriers is greater than that in Pro homozygotes, but when the dietary ratio is high, the opposite is seen. This gene-nutrient interaction emphasizes the difficulty of examining the effect of common polymorphisms in the absence of data on nongenetic exposures, and may explain the heterogeneity of findings in previous studies.
Similar articles
- Does peroxisome proliferator-activated receptor gamma genotype (Pro12ala) modify the association of physical activity and dietary fat with fasting insulin level?
Franks PW, Luan J, Browne PO, Harding AH, O'Rahilly S, Chatterjee VK, Wareham NJ. Franks PW, et al. Metabolism. 2004 Jan;53(1):11-6. doi: 10.1016/j.metabol.2003.08.005. Metabolism. 2004. PMID: 14681835 - Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass.
Memisoglu A, Hu FB, Hankinson SE, Manson JE, De Vivo I, Willett WC, Hunter DJ. Memisoglu A, et al. Hum Mol Genet. 2003 Nov 15;12(22):2923-9. doi: 10.1093/hmg/ddg318. Epub 2003 Sep 23. Hum Mol Genet. 2003. PMID: 14506127 - Central obesity and body fat, but not body mass index, are associated with the Pro12Ala polymorphism in the peroxisome proliferator-activated receptor γ gene in a population with a high consumption of saturated and trans-fatty acids.
Aguayo-Armendáriz J, Montalvo-Corral M, González-Martínez KA, Grijalva-Haro MI, Ballesteros-Vásquez MN, Caire-Juvera G, Moya-Camarena SY. Aguayo-Armendáriz J, et al. Nutr Res. 2018 Sep;57:28-35. doi: 10.1016/j.nutres.2018.05.003. Epub 2018 May 17. Nutr Res. 2018. PMID: 30122193 - The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism.
Stumvoll M, Häring H. Stumvoll M, et al. Diabetes. 2002 Aug;51(8):2341-7. doi: 10.2337/diabetes.51.8.2341. Diabetes. 2002. PMID: 12145143 Review. - The role of PPARgamma in high-fat diet-induced obesity and insulin resistance.
Kadowaki T, Hara K, Kubota N, Tobe K, Terauchi Y, Yamauchi T, Eto K, Kadowaki H, Noda M, Hagura R, Akanuma Y. Kadowaki T, et al. J Diabetes Complications. 2002 Jan-Feb;16(1):41-5. doi: 10.1016/s1056-8727(01)00206-9. J Diabetes Complications. 2002. PMID: 11872365 Review.
Cited by
- Genetic prediction of future type 2 diabetes.
Lyssenko V, Almgren P, Anevski D, Orho-Melander M, Sjögren M, Saloranta C, Tuomi T, Groop L; Botnia Study Group. Lyssenko V, et al. PLoS Med. 2005 Nov 1;2(12):e345. doi: 10.1371/journal.pmed.0020345. PLoS Med. 2005. PMID: 17570749 Free PMC article. Clinical Trial. - Genetics of obesity: more complicated than initially thought.
Shuldiner AR, Munir KM. Shuldiner AR, et al. Lipids. 2003 Feb;38(2):97-101. doi: 10.1007/s11745-003-1037-5. Lipids. 2003. PMID: 12733739 Review. - Genetic variants in DBC1, SIRT1, UCP2 and ADRB2 as potential biomarkers for severe obesity and metabolic complications.
da Fonseca ACP, Assis ISDS, Salum KCR, Palhinha L, Abreu GM, Zembrzuski VM, Campos Junior M, Nogueira-Neto JF, Cambraia A, Souza Junior MLF, Maya-Monteiro CM, Cabello PH, Bozza PT, Carneiro JRI. da Fonseca ACP, et al. Front Genet. 2024 May 22;15:1363417. doi: 10.3389/fgene.2024.1363417. eCollection 2024. Front Genet. 2024. PMID: 38841722 Free PMC article. - Genetics of insulin resistance.
Mercado MM, McLenithan JC, Silver KD, Shuldiner AR. Mercado MM, et al. Curr Diab Rep. 2002 Feb;2(1):83-95. doi: 10.1007/s11892-002-0063-9. Curr Diab Rep. 2002. PMID: 12643127 Review. - Genetic and environmental aspect of polycystic ovary syndrome.
Carmina E. Carmina E. J Endocrinol Invest. 2003 Nov;26(11):1151-9. doi: 10.1007/BF03345266. J Endocrinol Invest. 2003. PMID: 15008257 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials